Confirmation of the association of TMPRSS2(exon 0):ERG expression and a favorable prognosis of primary prostate cancer

European Urology

Volumn 60, Issue 1, 2011, Pages 183-184

  Boormans, Joost L ^a   Porkka, Kati ^b   Visakorpi, Tapio ^b   Trapman, Jan ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EXON; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; LETTER; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; PROSTATECTOMY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GENE;

EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEIN C-ETS-1; SERINE ENDOPEPTIDASES;

EID: 79957941300     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.03.028     Document Type: Letter

References (5)

1. S.A. Tomlins, D.R. Rhodes, and S. Perner Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer Science 310 2005 644 648 (Pubitemid 41528150)
2. J. Clark, S. Merson, and S. Jhavar Diversity of TMPRSS2-ERG fusion transcripts in the human prostate Oncogene 26 2007 2667 2673 (Pubitemid 46632014)
3. J. Lapointe, Y.H. Kim, and M.A. Miller A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis Mod Pathol 20 2007 467 473 (Pubitemid 46482370)
4. K.G. Hermans, J.L. Boormans, and D. Gasi Overexpression of prostate-specific TMPRSS2(exon 0)-ERG fusion transcripts corresponds with favorable prognosis of prostate cancer Clin Cancer Res 15 2009 6398 6403
5. J.I. Epstein, W.C. Allsbrook Jr., and M.B. Amin ISUP Grading Committee. The 2005 International Society of Urologic Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma Am J Surg Pathol 29 2005 1228 1242 (Pubitemid 41232997)